Telomere dysfunction cooperates with epigenetic alterations to impair murine embryonic stem cell fate commitment

  1. Mélanie Criqui
  2. Aditi Qamra
  3. Tsz Wai Chu
  4. Monika Sharma
  5. Julissa Tsao
  6. Danielle A Henry
  7. Dalia Barsyte-Lovejoy
  8. Cheryl H Arrowsmith
  9. Neil Winegarden
  10. Mathieu Lupien
  11. Lea Harrington  Is a corresponding author
  1. University of Montreal, Canada
  2. University Health Network, Canada
  3. McGill University Health Centre, Canada
  4. University of Toronto, Canada
  5. University Heath Network, Canada

Abstract

The precise relationship between epigenetic perturbations and telomere dysfunction is an extant question. Previously, we showed that telomere dysfunction leads to differentiation instability in murine embryonic stem cells (mESCs) via perturbations in DNA methylation at pluripotency-factor promoters. Here, we uncovered that telomerase reverse transcriptase null (Tert-/-) mESCs exhibit genome-wide perturbations in chromatin accessibility and gene expression during differentiation. These changes were accompanied by an increase of H3K27me3 globally, an altered chromatin landscape at the Pou5f1/Oct4 pluripotency gene promoter, and impaired Tert-/- mESC differentiation. Inhibition of the Polycomb Repressive Complex 2 (PRC2), an H3K27 tri-methyltransferase, exacerbated the impairment in differentiation and pluripotency gene repression in Tert-/- mESCs but not wild-type mESCs, whereas inhibition of H3K27me3 demethylation led to a partial rescue of the Tert-/- phenotype. This data reveals a new interdependent relationship between H3K27me3 and telomere integrity in stem cell lineage commitment that may have implications in aging and cancer.

Data availability

ATAC-seq and ChIP-seq data has been deposited in GEO under accession number GSE130780 and GSE146322. The Metadata sheet accompanying this deposition is provided in Figure 4 - source data files 2 and 4.

The following data sets were generated

Article and author information

Author details

  1. Mélanie Criqui

    Department of Molecular Biology, University of Montreal, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  2. Aditi Qamra

    Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  3. Tsz Wai Chu

    Clinical Research Unit, McGill University Health Centre, Montréal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  4. Monika Sharma

    Princess Margaret Genomics Centre, University Health Network, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  5. Julissa Tsao

    Princess Margaret Genomics Centre, University Health Network, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  6. Danielle A Henry

    Department of Molecular Biology, University of Montreal, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  7. Dalia Barsyte-Lovejoy

    Structural Genomics Consortium, University of Toronto, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  8. Cheryl H Arrowsmith

    Structural Genomics Consortium, University of Toronto, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  9. Neil Winegarden

    Princess Margaret Genomics Centre, University Heath Network, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  10. Mathieu Lupien

    Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0929-9478
  11. Lea Harrington

    Department of Medicine, University of Montreal, Montreal, Canada
    For correspondence
    lea.harrington@umontreal.ca
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4977-2744

Funding

Canadian Institutes of Health Research (367427)

  • Lea Harrington

Canadian Institutes of Health Research (133573)

  • Lea Harrington

Wellcome (084637)

  • Lea Harrington

Ontario Genomics Institute (OGI-055)

  • Cheryl H Arrowsmith

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Criqui et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,701
    views
  • 350
    downloads
  • 14
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Mélanie Criqui
  2. Aditi Qamra
  3. Tsz Wai Chu
  4. Monika Sharma
  5. Julissa Tsao
  6. Danielle A Henry
  7. Dalia Barsyte-Lovejoy
  8. Cheryl H Arrowsmith
  9. Neil Winegarden
  10. Mathieu Lupien
  11. Lea Harrington
(2020)
Telomere dysfunction cooperates with epigenetic alterations to impair murine embryonic stem cell fate commitment
eLife 9:e47333.
https://doi.org/10.7554/eLife.47333

Share this article

https://doi.org/10.7554/eLife.47333

Further reading

    1. Chromosomes and Gene Expression
    Jake VanBelzen, Bennet Sakelaris ... Jason H Brickner
    Research Article

    Chromatin immunoprecipitation (ChIP-seq) is the most common approach to observe global binding of proteins to DNA in vivo. The occupancy of transcription factors (TFs) from ChIP-seq agrees well with an alternative method, chromatin endogenous cleavage (ChEC-seq2). However, ChIP-seq and ChEC-seq2 reveal strikingly different patterns of enrichment of yeast RNA polymerase II (RNAPII). We hypothesized that this reflects distinct populations of RNAPII, some of which are captured by ChIP-seq and some of which are captured by ChEC-seq2. RNAPII association with enhancers and promoters - predicted from biochemical studies - is detected well by ChEC-seq2 but not by ChIP-seq. Enhancer/promoter-bound RNAPII correlates with transcription levels and matches predicted occupancy based on published rates of enhancer recruitment, preinitiation assembly, initiation, elongation, and termination. The occupancy from ChEC-seq2 allowed us to develop a stochastic model for global kinetics of RNAPII transcription which captured both the ChEC-seq2 data and changes upon chemical-genetic perturbations to transcription. Finally, RNAPII ChEC-seq2 and kinetic modeling suggests that a mutation in the Gcn4 transcription factor that blocks interaction with the NPC destabilizes promoter-associated RNAPII without altering its recruitment to the enhancer.

    1. Chromosomes and Gene Expression
    2. Microbiology and Infectious Disease
    Maruti Nandan Rai, Qing Lan ... Koon Ho Wong
    Research Article Updated

    Candida glabrata can thrive inside macrophages and tolerate high levels of azole antifungals. These innate abilities render infections by this human pathogen a clinical challenge. How C. glabrata reacts inside macrophages and what is the molecular basis of its drug tolerance are not well understood. Here, we mapped genome-wide RNA polymerase II (RNAPII) occupancy in C. glabrata to delineate its transcriptional responses during macrophage infection in high temporal resolution. RNAPII profiles revealed dynamic C. glabrata responses to macrophages with genes of specialized pathways activated chronologically at different times of infection. We identified an uncharacterized transcription factor (CgXbp1) important for the chronological macrophage response, survival in macrophages, and virulence. Genome-wide mapping of CgXbp1 direct targets further revealed its multi-faceted functions, regulating not only virulence-related genes but also genes associated with drug resistance. Finally, we showed that CgXbp1 indeed also affects fluconazole resistance. Overall, this work presents a powerful approach for examining host-pathogen interaction and uncovers a novel transcription factor important for C. glabrata’s survival in macrophages and drug tolerance.